De Mangia A et al. Global real world evidence of sofosbuvir/verplatasvir as a simple effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts. (Abstract GS-03)
Bulevirtide veelbelovend tegen hepatitis D, maar nog veel vragen
jul 2021 | Hepatitis, Hepatologie